
The impact of hyperthermia on survival and pharmacokinetics in cisplatin HIPEC in stage III epithelial ovarian cancer
- Author
- Jesse Demuytere (UGent) , Charlotte Carlier, Wouter Willaert (UGent) , Philippe Tummers (UGent) , Hannelore Denys (UGent) , Tom Van Helden (UGent) , Joke Belza (UGent) , Frank Vanhaecke (UGent) , Feifan Xie, An Vermeulen (UGent) , Olivier Van Kerschaver, Joseph Weerts, Sarah Cosyns (UGent) and Wim Ceelen (UGent)
- Organization
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-01JE40B62XZGHGZD88T9AQCN34
- MLA
- Demuytere, Jesse, et al. “The Impact of Hyperthermia on Survival and Pharmacokinetics in Cisplatin HIPEC in Stage III Epithelial Ovarian Cancer.” ANNALS OF SURGICAL ONCOLOGY, vol. 29, no. Supplement 2, 2022, pp. 523–523.
- APA
- Demuytere, J., Carlier, C., Willaert, W., Tummers, P., Denys, H., Van Helden, T., … Ceelen, W. (2022). The impact of hyperthermia on survival and pharmacokinetics in cisplatin HIPEC in stage III epithelial ovarian cancer. ANNALS OF SURGICAL ONCOLOGY, 29(Supplement 2), 523–523.
- Chicago author-date
- Demuytere, Jesse, Charlotte Carlier, Wouter Willaert, Philippe Tummers, Hannelore Denys, Tom Van Helden, Joke Belza, et al. 2022. “The Impact of Hyperthermia on Survival and Pharmacokinetics in Cisplatin HIPEC in Stage III Epithelial Ovarian Cancer.” In ANNALS OF SURGICAL ONCOLOGY, 29:523–523.
- Chicago author-date (all authors)
- Demuytere, Jesse, Charlotte Carlier, Wouter Willaert, Philippe Tummers, Hannelore Denys, Tom Van Helden, Joke Belza, Frank Vanhaecke, Feifan Xie, An Vermeulen, Olivier Van Kerschaver, Joseph Weerts, Sarah Cosyns, and Wim Ceelen. 2022. “The Impact of Hyperthermia on Survival and Pharmacokinetics in Cisplatin HIPEC in Stage III Epithelial Ovarian Cancer.” In ANNALS OF SURGICAL ONCOLOGY, 29:523–523.
- Vancouver
- 1.Demuytere J, Carlier C, Willaert W, Tummers P, Denys H, Van Helden T, et al. The impact of hyperthermia on survival and pharmacokinetics in cisplatin HIPEC in stage III epithelial ovarian cancer. In: ANNALS OF SURGICAL ONCOLOGY. 2022. p. 523–523.
- IEEE
- [1]J. Demuytere et al., “The impact of hyperthermia on survival and pharmacokinetics in cisplatin HIPEC in stage III epithelial ovarian cancer,” in ANNALS OF SURGICAL ONCOLOGY, Dallas, TX, USA, 2022, vol. 29, no. Supplement 2, pp. 523–523.
@inproceedings{01JE40B62XZGHGZD88T9AQCN34, articleno = {{III}}, author = {{Demuytere, Jesse and Carlier, Charlotte and Willaert, Wouter and Tummers, Philippe and Denys, Hannelore and Van Helden, Tom and Belza, Joke and Vanhaecke, Frank and Xie, Feifan and Vermeulen, An and Van Kerschaver, Olivier and Weerts, Joseph and Cosyns, Sarah and Ceelen, Wim}}, booktitle = {{ANNALS OF SURGICAL ONCOLOGY}}, issn = {{1068-9265}}, language = {{eng}}, location = {{Dallas, TX, USA}}, number = {{Supplement 2}}, pages = {{III:523--III:523}}, title = {{The impact of hyperthermia on survival and pharmacokinetics in cisplatin HIPEC in stage III epithelial ovarian cancer}}, volume = {{29}}, year = {{2022}}, }